{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:35:40Z","timestamp":1787502940457,"version":"build-2736575974"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The serious challenge of antimicrobial resistance continues to threaten public health and lingers in the era of the coronavirus disease 2019 (COVID-19), declared pandemic by the World Health Organization. While the pandemic has triggered the importance of infection control practices and preventive measures such as physical distancing, hand hygiene, travel reduction and quarantine, the ongoing alarm of antimicrobial resistance seems to accompany the pandemic too. Antimicrobial resistance has been fostered during COVID-19, possibly due to high rate of empirical antibiotic utilization in COVID-19 patients, increased use of biocides, and the disruption of proper healthcare for other conditions. Specifically, carbapenemase-producing Gram-negative bacteria have shown to cause secondary bacterial infections in patients hospitalized for COVID-19. Clinical and microbiological evidence of such infections is accumulating in different parts of the world. With the resilient nature of carbapenemases, their association with mortality, and the limited treatment options available, concerns regarding this group of antibiotic-hydrolyzing enzymes during the pandemic are expected to upsurge. While the additional burden carbapenemases exert on healthcare is worrisome, it remains hidden or abandoned among the various health consequences of the pandemic. The purpose of this minireview is to shed a light on carbapenemase-associated infections during such unprecedented time of COVID-19. A focused insight shall be made into carbapenemases, their implications for COVID-19 patients, and the features and consequences of co-infection, with a review of available evidence from pertinent literature. The importance of increased surveillance for carbapenemase-producers and optimizing their management in relation to the pandemic, shall be addressed as well.<\/jats:p>","DOI":"10.3389\/fcimb.2022.823626","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T01:46:27Z","timestamp":1647481587000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens"],"prefix":"10.3389","volume":"12","author":[{"given":"Carole","family":"Ayoub Moubareck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal","family":"Hammoudi Halat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1186\/s12879-021-06642-2","article-title":"Co-Infection of ST2IP Carbapenem-Resistant Acinetobacter Baumannii With SARS-CoV-2 in the Patients Admitted to a Tehran Tertiary Referral Hospital","volume":"21","author":"Abdollahi","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.ajic.2021.07.004","article-title":"Outbreak of NDM-1-Producing Klebsiella Pneumoniae in the Intensive Care Unit During the COVID-19 Pandemic: Another Nightmare","volume":"49","author":"Amarsy","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106245","article-title":"Klebsiella Pneumoniae Infections in COVID-19 Patients: A 2-Month Retrospective Analysis in an Italian Hospital","volume":"57","author":"Arcari","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2020.1401","article-title":"A Multidrug-Resistant Klebsiella Pneumoniae Outbreak in a Peruvian Hospital: Another Threat From the COVID-19 Pandemic","author":"Arteaga-Livias","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9030119","article-title":"Insights Into Acinetobacter Baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiot (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijid.2019.04.027","article-title":"Role of Outer Membrane Permeability, Efflux Mechanism, and Carbapenemases in Carbapenem-Nonsusceptible Pseudomonas Aeruginosa From Dubai Hospitals: Results of the First Cross-Sectional Survey","volume":"84","author":"Ayoub Moubareck","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7957","DOI":"10.1021\/acs.chemrev.1c00138","article-title":"Metallo-\u03b2-Lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design","volume":"121","author":"Bahr","year":"2021","journal-title":"Chem. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1080\/21645515.2020.1810496","article-title":"Global Scenario, Public Health Concerns and Mitigation Strategies to Counter Current Ongoing SARS-CoV-2 \/ COVID-19 Pandemic","volume":"16","author":"Barbuddhe","year":"2020","journal-title":"Hum. Vaccin Immunother."},{"key":"B9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jhin.2020.11.030","article-title":"Impact of SARS CoV-2 Pandemic on Carbapenemase-Producing Klebsiella Pneumoniae Prevention and Control Programme: Convergent or Divergent Action","volume":"109","author":"Belvisi","year":"2021","journal-title":"J. Hosp Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1177\/0020731420946594","article-title":"We Must Take Advantage of This Pandemic to Make a Radical Social Change: The Coronavirus as a Global Health, Inequality, and Eco-Social Problem","volume":"51","author":"Benach","year":"2021","journal-title":"Int. J. Health Serv."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-Producing Organisms: A Global Scourge","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1093\/jac\/dku391","article-title":"Characterization of a New Genetic Environment Associated With GES-6 Carbapenemase From a Pseudomonas Aeruginosa Isolate Belonging to the High-Risk Clone ST235","volume":"70","author":"Botelho","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/QCO.0000000000000608","article-title":"Epidemiology of Carbapenem-Resistant Gram-Negative Infections Globally","volume":"32","author":"Brink","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01076-18","article-title":"Past and Present Perspectives on \u03b2-Lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MCC.0000000000000755","article-title":"Antimicrobial Resistance in ICUs: An Update in the Light of the COVID-19 Pandemic","volume":"26","author":"Cant\u00f3n","year":"2020","journal-title":"Curr. Opin. Crit. Care"},{"key":"B16","first-page":"256","article-title":"Guidance for Control of Infections With Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3201\/eid2109.150198","article-title":"Improved Phenotype-Based Definition for Identifying Carbapenemase Producers Among Carbapenem-Resistant Enterobacteriaceae","volume":"21","author":"Chea","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.2147\/IDR.S311968","article-title":"Shift in the Dominant Sequence Type of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infection From ST11 to ST15 at a Medical Center in Northeast Chin","volume":"14","author":"Chen","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18084358","article-title":"Co-Infections in Critically Ill Patients With or Without COVID-19: A Comparison of Clinical Microbial Culture Findings","volume":"18","author":"Cultrera","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B21","first-page":"51","article-title":"Blood Stream Infections During the First Wave of COVID-19. A Short Microbiological Retrospective Picture at Papa Giovanni XXIII Hospital, Bergamo, Italy","volume":"44","author":"Cuntr\u00f2","year":"2021","journal-title":"New Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3855\/jidc.11341","article-title":"Acinetobacter Spp in a Third World Country With Socio-Economic and Immigrants Challenges","volume":"13","author":"Dandachi","year":"2019","journal-title":"J. Infect. Dev. Ctries"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10101146","article-title":"The Impact of COVID-19 on the Profile of Hospital-Acquired Infections in Adult Intensive Care Units","volume":"10","author":"Despotovic","year":"2021","journal-title":"Antibiotics"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.574198","article-title":"Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond","volume":"8","author":"Dhama","year":"2020","journal-title":"Front. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhin.2020.05.020","article-title":"Multi-Drug-Resistant Infections in the COVID-19 Era: A Framework for Considering the Potential Impact","volume":"106","author":"Don\u00e0","year":"2020","journal-title":"J.\u00a0Hosp Infect."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/249856","article-title":"Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria","volume":"2014","author":"Dortet","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10050561","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae Associated With COVID-19","volume":"10","author":"Dumitru","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.ajic.2020.09.015","article-title":"Carbapenemase-Producing Enterobacterales Outbreak: Another Dark Side of COVID-19","volume":"48","author":"Farfour","year":"2020","journal-title":"Am. J. Infect. Control"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104588","article-title":"Evolving Trends of New Delhi Metallo-Betalactamse (NDM) Variants: A Threat to Antimicrobial Resistance","volume":"86","author":"Farhat","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2020.152222","article-title":"Generalized Anxiety and Depressive Symptoms in Various Age Groups During the COVID-19 Lockdown in Poland. Specific Predictors and Differences in Symptoms Severity","volume":"105","author":"Gambin","year":"2021","journal-title":"Compr. Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jiph.2020.11.001","article-title":"Spread of OXA-48-Producing Klebsiella Pneumoniae Among COVID-19-Infected Patients: The Storm After the Storm","volume":"14","author":"Garc\u00eda-Meni\u00f1o","year":"2021","journal-title":"J. Infect Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.diagmicrobio.2014.09.029","article-title":"Widespread of ESBL- and Carbapenemase GES-Type Genes on Carbapenem-Resistant Pseudomonas Aeruginosa Clinical Isolates: A Multicenter Study in Mexican Hospitals","volume":"81","author":"Garza-Ramos","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jac\/dkaa466","article-title":"Carbapenemase-Producing Enterobacterales Causing Secondary Infections During the COVID-19 Crisis at a New York City Hospital","volume":"76","author":"Gomez-Simmonds","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9040186","article-title":"The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination Among Gram-Negative Bacteria","volume":"9","author":"Hammoudi Halat","year":"2020","journal-title":"Antibiot (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.mimet.2014.09.009","article-title":"How to Detect Carbapenemase Producers? A Literature Review of Phenotypic and Molecular Methods","volume":"107","author":"Hammoudi","year":"2014","journal-title":"J. Microbiol. Methods"},{"key":"B36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40121-020-00395-2","article-title":"Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria","volume":"10","author":"Hansen","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.cmi.2020.06.025","article-title":"Bacterial and Fungal Coinfection Among Hospitalized Patients With COVID-19: A Retrospective Cohort Study in a UK Secondary-Care Setting","volume":"26","author":"Hughes","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B38","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/jac\/dkx393","article-title":"Ceftazidime\/avibactam Alone or in Combination With Aztreonam Against Colistin-Resistant and Carbapenemase-Producing Klebsiella Pneumoniae","volume":"73","author":"Jayol","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1128\/AAC.00762-13","article-title":"Structures of the Class D Carbapenemases OXA-23 and OXA-146: Mechanistic Basis of Activity Against Carbapenems, Extended-Spectrum Cephalosporins, and Aztreonam","volume":"57","author":"Kaitany","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s15010-020-01520-6","article-title":"Treatment Options for K. Pneumoniae, P. Aeruginosa and A. Baumannii Co-Resistant to Carbapenems, Aminoglycosides, Polymyxins and Tigecycline: An Approach Based on the Mechanisms of Resistance to Carbapenems","volume":"48","author":"Karakonstantis","year":"2020","journal-title":"Infection"},{"key":"B41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12941-021-00454-7","article-title":"Secondary Bacterial Infections and Antimicrobial Resistance in COVID-19: Comparative Evaluation of Pre-Pandemic and Pandemic-Era, a Retrospective Single Center Study","volume":"20","author":"Karata\u015f","year":"2021","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/mdr.2020.0489","article-title":"Multidrug-Resistant Infections and Outcome of Critically Ill Patients With Coronavirus Disease 2019: A Single Center Experience","volume":"27","author":"Karruli","year":"2021","journal-title":"Microb. Drug Resist"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10040480","article-title":"Correlation Between Acinetobacter Baumannii Resistance and Hospital Use of Meropenem, Cefepime, and Ciprofloxacin: Time Series Analysis and Dynamic Regression Models","volume":"10","author":"Kousovista","year":"2021","journal-title":"Pathogens"},{"key":"B44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/mdr.2012.0219","article-title":"OXA-48 Carbapenemase-Producing Klebsiella Pneumoniae Isolated From Libyan Patients","volume":"19","author":"Lafeuille","year":"2013","journal-title":"Microb. Drug Resist."},{"key":"B45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.51893\/2020.2.oa1","article-title":"Critically Ill Patients With COVID-19 in Hong Kong: A Multicentre Retrospective Observational Cohort Study","volume":"22","author":"Ling","year":"2020","journal-title":"Crit. Care Resusc"},{"key":"B46","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jacamr\/dlab052","article-title":"Antibiotic Resistance During and Beyond COVID-19","volume":"3","author":"Livermore","year":"2021","journal-title":"JAC Antimicrob. Resist."},{"key":"B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13756-020-00819-1","article-title":"Etiology and Antimicrobial Resistance of Secondary Bacterial Infections in Patients Hospitalized With COVID-19 in Wuhan, China: A Retrospective Analysis","volume":"9","author":"Li","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1093\/infdis\/jiw282","article-title":"The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace","volume":"215","author":"Logan","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10102067","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae Infections in ICU COVID-19 Patients-A Scoping Review","volume":"10","author":"M\u0119drzycka-D\u0105browska","year":"2021","journal-title":"J. Clin. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10964-020-01332-9","article-title":"Risk and Protective Factors for Prospective Changes in Adolescent Mental Health During the COVID-19 Pandemic","volume":"50","author":"Magson","year":"2021","journal-title":"J. Youth Adolesc."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e02243","DOI":"10.1128\/AAC.02243-16","article-title":"Can Ceftazidime-Avibactam and Aztreonam Overcome \u03b2-Lactam Resistance Conferred by Metallo-\u03b2-Lactamases in Enterobacteriaceae","volume":"61","author":"Marshall","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jac\/dkaa400","article-title":"Antimicrobial Stewardship Challenges and Innovative Initiatives in the Acute Hospital Setting During the COVID-19 Pandemic","volume":"76","author":"Martin","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.683409","article-title":"Dynamics of SARS-CoV2 Infection and Multi-Drug Resistant Bacteria Superinfection in Patients With Assisted Mechanical Ventilation","volume":"11","author":"Mazzariol","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"346","DOI":"10.25259\/SNI_514_2021","article-title":"Ventricular Empyema Associated With Severe Pyogenic Meningitis in COVID-19 Adult Patient: Case Report","volume":"12","author":"Meguins","year":"2021","journal-title":"Surg. Neurol. Int."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001886","article-title":"Will Coronavirus Disease (COVID-19) Have an Impact on Antimicrobial Resistance","volume":"25","author":"Monnet","year":"2020","journal-title":"Euro Surveill"},{"key":"B56","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jgar.2020.11.004","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae in ICU-Admitted COVID-19 Patients: Keep an Eye on the Ball","volume":"23","author":"Montrucchio","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2174\/1389450117666160310144501","article-title":"Structural and Functional Aspects of Class A Carbapenemases","volume":"17","author":"Naas","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/AAC.38.6.1262","article-title":"Cloning and Sequence Analysis of the Gene for a Carbapenem-Hydrolyzing Class A Beta-Lactamase, Sme-1, From Serratia Marcescens S6","volume":"38","author":"Naas","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1128\/AAC.37.5.939","article-title":"Biochemical Properties of a Carbapenem-Hydrolyzing Beta-Lactamase From Enterobacter Cloacae and Cloning of the Gene Into Escherichia Coli","volume":"37","author":"Nordmann","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/ice.2020.368","article-title":"Bacterial and Fungal Coinfections in COVID-19 Patients Hospitalized During the New York City Pandemic Surge","volume":"42","author":"Nori","year":"2021","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MEJ.0000000000000713","article-title":"Infodemic and the Spread of Fake News in the COVID-19-Era","volume":"27","author":"Orso","year":"2020","journal-title":"Eur. J. Emerg. Med"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2021.144","article-title":"Carbapenem Resistant Bacteria in Intensive Care Unit During COVID-19 Pandemic: Multicenter Before-After Cross Sectional Study","author":"Pascale","year":"2021","journal-title":"Infect. Control Hosp Epidemiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","article-title":"Colistin Alone Versus Colistin Plus Meropenem for Treatment of Severe Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria: An Open-Label, Randomised Controlled Trial","volume":"18","author":"Paul","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.15585\/mmwr.mm6948e1","article-title":"Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter Baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020","volume":"69","author":"Perez","year":"2020","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23744235.2021.1963471","article-title":"Carbapenemase-Producing Enterobacterales Infections in COVID-19 Patients","volume":"54","author":"Pintado","year":"2022","journal-title":"Infect. Dis. (Lond)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-19","article-title":"The Global Ascendency of OXA-48-Type Carbapenemases","volume":"33","author":"Pitout","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1128\/AAC.48.1.15-22.2004","article-title":"Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella Pneumoniae","volume":"48","author":"Poirel","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1093\/jac\/dks121","article-title":"OXA-48-Like Carbapenemases: The Phantom Menace","volume":"67","author":"Poirel","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","article-title":"Impact of the COVID-19 Pandemic on the Incidence of Multidrug-Resistant Bacterial Infections in an Acute Care Hospital in Brazil","volume":"50","author":"Polly","year":"2021","journal-title":"Am. J. Infect Control"},{"key":"B70","doi-asserted-by":"publisher","first-page":"E635","DOI":"10.3390\/pathogens9080635","article-title":"Increased Risk of Acquisition of New Delhi Metallo-Beta-Lactamase-Producing Carbapenem-Resistant Enterobacterales (NDM-CRE) Among a Cohort of COVID-19 Patients in a Teaching Hospital in Tuscany, Italy","volume":"9","author":"Porretta","year":"2020","journal-title":"Pathogens"},{"key":"B71","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The Rapid Spread of Carbapenem-Resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist. Update"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2020.100086","article-title":"Recommendations for Detection and Rapid Management of Carbapenemase-Producing Enterobacterales Outbreaks","volume":"2","author":"Puleston","year":"2020","journal-title":"Infect. Prev. Pract."},{"key":"B73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2014.01.004","article-title":"First Report of blaNDM-1-Producing Acinetobacter Baumannii Isolated in Lebanon From Civilians Wounded During the Syrian War","volume":"21","author":"Rafei","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.2147\/IDR.S272605","article-title":"Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report From Upper Egypt","volume":"13","author":"Ramadan","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","article-title":"COVID-19 and the Potential Long-Term Impact on Antimicrobial Resistance","volume":"75","author":"Rawson","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e00079","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/life11030220","article-title":"Implications of COVID-19 Pandemic on the Emergence of Antimicrobial Resistance: Adjusting the Response to Future Outbreaks","volume":"11","author":"Rusic","year":"2021","journal-title":"Life (Basel)"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","article-title":"Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalised With COVID-19 During the First Pandemic Wave From the ISARIC WHO CCP-UK Study: A Multicentre, Prospective Cohort Study","volume":"2","author":"Russell","year":"2021","journal-title":"Lancet Microbe"},{"key":"B79","doi-asserted-by":"publisher","first-page":"apm","DOI":"10.21037\/apm-21-833","article-title":"Secondary Infection in Severe and Critical COVID-19 Patients in China: A Multicenter Retrospective Study","author":"Sang","year":"2021","journal-title":"Ann. Palliat Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40560-020-0429-6","article-title":"Molecular Diversity of Extended-Spectrum \u03b2-Lactamases and Carbapenemases, and Antimicrobial Resistance","volume":"8","author":"Sawa","year":"2020","journal-title":"J. Intensive Care"},{"key":"B81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/jac\/36.3.585","article-title":"Transferable Imipenem-Resistance in Acinetobacter Species From a Clinical Source","volume":"36","author":"Scaife","year":"1995","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"B82","doi-asserted-by":"publisher","first-page":"dkab169","DOI":"10.1093\/jac\/dkab169","article-title":"Rapid Spread of Critical Priority Carbapenemase-Producing Pathogens in Companion Animals: A One Health Challenge for a Post-Pandemic World","author":"Sellera","year":"2021","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2147\/IDR.S314029","article-title":"Coinfections in Patients Hospitalized With COVID-19: A Descriptive Study From the United Arab Emirates","volume":"14","author":"Senok","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B84","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/bi501052t","article-title":"Kinetic and Structural Requirements for Carbapenemase Activity in GES-Type \u03b2-Lactamases","volume":"54","author":"Stewart","year":"2015","journal-title":"Biochemistry"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030122","article-title":"Present and Future of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections","volume":"8","author":"Suay-Garc\u00eda","year":"2019","journal-title":"Antibiot. (Basel)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, Research, and Development of New Antibiotics: The WHO Priority List of Antibiotic-Resistant Bacteria and Tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B87","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.cmi.2019.01.005","article-title":"ESCMID-EUCIC Clinical Guidelines on Decolonization of Multidrug-Resistant Gram-Negative Bacteria Carriers","volume":"25","author":"Tacconelli","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092744","article-title":"Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work","volume":"9","author":"Tiri","year":"2020","journal-title":"J. Clin. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1574-6968.2006.00195.x","article-title":"The Role of ISAba1 in Expression of OXA Carbapenemase Genes in Acinetobacter Baumannii","volume":"258","author":"Turton","year":"2006","journal-title":"FEMS Microbiol. Lett."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2217\/fmb-2020-0069","article-title":"The Present Danger of New Delhi Metallo-\u03b2-Lactamase: A Threat to Public Health","volume":"15","author":"Usman Qamar","year":"2020","journal-title":"Future Microbiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","article-title":"A Novel Coronavirus Outbreak of Global Health Concern","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2021.03.018","article-title":"Bacterial Coinfections in Coronavirus Disease 2019","author":"Westblade","year":"2021","journal-title":"Trends Microbiol."},{"key":"B94","unstructured":"WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed"},{"key":"B95","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(20)30557-2","article-title":"SARS-CoV-2 Is an Appropriate Name for the New Coronavirus","volume":"395","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"B96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jiac.2016.09.006","article-title":"Nosocomial Spread of Klebsiella Pneumoniae Isolates Producing blaGES-4 Carbapenemase at a Japanese Hospital","volume":"23","author":"Yamasaki","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"B97","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/AAC.34.5.755","article-title":"Biochemical Characterization of a Beta-Lactamase That Hydrolyzes Penems and Carbapenems From Two Serratia Marcescens Isolates","volume":"34","author":"Yang","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10096-019-03711-y","article-title":"Breakpoint Beware: Reliance on Historical Breakpoints for Enterobacteriaceae Leads to Discrepancies in Interpretation of Susceptibility Testing for Carbapenems and Cephalosporins and Gaps in Detection of Carbapenem-Resistant Organisms","volume":"39","author":"Yarbrough","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a New Metallo-Beta-Lactamase Gene, Bla(NDM-1), and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella Pneumoniae Sequence Type 14 From India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.35663\/amp.2020.373.1277","article-title":"Medicaci\u00f3n Prehospitalaria En Pacientes Hospitalizados Por COVID-19 En Un Hospital P\u00fablico De Lima-Per\u00fa","volume":"37","author":"Zavala-Flores","year":"2020","journal-title":"Acta Med. PERUANA"},{"key":"B101","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12939-021-01390-w","article-title":"A Hidden Side of the COVID-19 Pandemic in Children: The Double Burden of Undernutrition and Overnutrition","volume":"20","author":"Zemrani","year":"2021","journal-title":"Int. J. Equity Health"},{"key":"B102","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A Siderophore Cephalosporin With Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"B103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40265-017-0851-9","article-title":"Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-\u03b2-Lactamase Inhibitor Combinations","volume":"78","author":"Zhanel","year":"2018","journal-title":"Drugs"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104364","article-title":"Clinical Features and Short-Term Outcomes of 221 Patients With COVID-19 in Wuhan, China","volume":"127","author":"Zhang","year":"2020","journal-title":"J. Clin. Virol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.823626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T01:46:32Z","timestamp":1647481592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.823626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":104,"alternative-id":["10.3389\/fcimb.2022.823626"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.823626","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,17]]},"article-number":"823626"}}